Skip to content

A Multicenter Randomized Controlled Trial of Motor-Cognitive Interactive Upper Limb Robotic Rehabilitation Intervention for Post-Stroke Motor Dysfunction

A Multicenter Randomized Controlled Trial of Motor-Cognitive Interactive Upper Limb Robotic Rehabilitation Intervention for Post-Stroke Motor Dysfunction

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500099863
Enrollment
Unknown
Registered
2025-03-31
Start date
2025-04-02
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with post-stroke upper limb motor dysfunction

Interventions

Motor-Dominant Upper Limb Robotic Rehabilitation Training Group:Administered as an adjunct to standard care, this protocol primarily focuses on motor skill enhancement through repetitive task-oriented
Conventional Upper Limb Rehabilitation Training Group:ntervention: Delivered alongside standard care, this group receives guideline-based task-oriented training protocols aligned with international cl
Motor-Cognitive Interactive Upper Limb Robotic Rehabilitation Training Group:Once daily 60-minute session, 5 days per week, over 4 weeks.

Sponsors

Shanghai Yangzhi rehabilitation hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Meeting the diagnostic criteria for stroke confirmed by CT or MRI; 2.Aged 40–80 years with no gender restriction; 3.First-ever stroke with unilateral hemiplegia; 4.Post-stroke duration of 2 weeks to 6 months and Fugl-Meyer Assessment of Upper Extremity (FMA-UE) score 8–38 points; 5.Voluntary participation with signed informed consent;

Exclusion criteria

Exclusion criteria: 1.History of neuromuscular disorders, malignancies, or severe uncontrolled systemic diseases (e.g., cardiovascular, renal, or hepatic diseases); 2.Seated balance 60 minutes; 3.Modified Ashworth Scale score >2 for muscle tone; 4.Visual Analog Scale (VAS) score >3 for hemiplegic shoulder pain; 5.Boston Diagnostic Aphasia Examination score 17 with moderate-to-severe depressive symptoms; 8.Concurrent participation in other clinical trials that may confound study outcomes;

Design outcomes

Primary

MeasureTime frame
Fugl-Meyer;

Secondary

MeasureTime frame
Activity of daily living;Upper limb muscle strength;Cognitive Function;

Countries

China

Contacts

Public ContactJin lingjing

Shanghai Yangzhi rehabilitation hospital

lingjingjin@163.com+86 21 66111329

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026